期刊
NUCLEAR MEDICINE AND BIOLOGY
卷 41, 期 7, 页码 594-599出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2014.04.008
关键词
Neuroinflammation; [C-11]ketoprofen methyl ester; NSAIDs; Dosimetry; Biodistribution
资金
- Grants-in-Aid for Scientific Research [24790269] Funding Source: KAKEN
Introduction: Neuroinflammatory processes play an important role in the pathogenesis of Alzheimer's disease and other brain disorders, and nonsteroidal anti-inflammatory drugs (NSAIDs) are considered therapeutic candidates. As a biomarker of neuroinflammatory processes, C-11-labeled ketoprofen methyl ester ([C-11]KTP-Me) was designed to allow cerebral penetration of ketoprofen (KTP), an active form of a selective cyclooxygenase-1 inhibitor that acts as an NSAID. Rat neuroinflammation models indicate that [C-11]KTP-Me enters the brain and is retained in inflammatory lesions, accumulating in activated microglia. [C-11]CTP-Me is washed out from normal tissues, leading to the present first-in-human exploratory study. Methods: [C-11]KTP-Me was synthesized by rapid C[C-11]methylation of [C-11]CH3(I) and the corresponding arylacetate precursor, purified with high-performance liquid chromatography, and prepared as an injectable solution including PEG400, providing radiochemical purity of >99% and specific activity of >25 GBq/mu mol at injection. Six young healthy male humans were injected with [C-11]KTP-Me and scanned with PET camera to determine the early-phase brain time course followed by three whole-body scans starting 8, 20, and 40 min post-injection, together with sequential blood sampling and labeled metabolite analysis. Results: No adverse effects were observed during PET scanning after [C-11]KTP-Me injection. [C-11]KTP-Me was rapidly metabolized to C-11-labeled ketoprofen ([C-11]KTP) within 2-3 min and was gradually cleared from blood. The radioactivity entered the brain with an average peak cortical SUV of 1.5 at 2 min. The cortical activity was gradually washed out. Whole-body images indicated that the urinary bladder was the major excretory pathway. The organ with the highest radiation dose was the urinary bladder (average dose of 41 mu Gy/MBq, respectively). The mean effective dose was 4.7 mu Sv/MBq, which was comparable to other C-11-labeled radiopharmaceuticals. Conclusion: [C-11]KTP-Me demonstrated a favorable dosimetry, biodistribution, and safety profile. [C-11]KTP-Me entered the human brain, and the radioactivity was washed out from cerebral tissue. These data warrant further exploratory studies on patients with neuroinflammation. (C) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据